文献速递慢阻肺

气道系统发育多样性丧失与慢阻肺疾病发展的临床和病理生物学标志物相关

Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

该研究基于SPIROMICS队列中877名参与者,采用16S rRNA基因测序分析痰液微生物组,发现气道微生物系统发育多样性与基线肺功能正相关,与症状负担、影像学气道疾病标志物及总黏蛋白浓度负相关(P < 0.001),且基线菌群特征与肺功能轨迹相关。

要点

  • 痰液微生物系统发育多样性与基线肺功能正相关,与症状负担及影像学小气道疾病标志物负相关。
  • 稳定/改善组基线细菌多样性较高,富集普雷沃菌属、纤毛菌属和奈瑟菌属。
  • 快速下降组基线多样性显著较低,富集链球菌属。

核心结论

  • 在SPIROMICS队列中,基线气道微生物群特征与更好或更差的慢阻肺相关结局呈现不同方向的关联。

研究设计与样本

  • 研究分析了SPIROMICS队列中877名参与者的痰液DNA,采用16S核糖体RNA基因测序。
  • 参与者数据主要代表较轻疾病,877名中有732名为GOLD 0-2级阻塞。
  • 分析了基线气道微生物群组成与临床、影像学和黏液炎症标志物的关系,包括纵向肺功能轨迹。

主要发现

  • 系统发育多样性与基线肺功能正相关,随GOLD分期升高而降低,与症状负担、影像学气道疾病标志物和总黏蛋白浓度负相关(P < 0.001)。
  • 在协变量调整回归模型中,与更好肺功能稳健相关的菌属包括Alloprevotella、Oribacterium和Veillonella。
  • 较低肺功能、更重症状和小气道疾病影像学指标与Streptococcus、Actinobacillus、Actinomyces等菌属富集相关。
  • 基线痰液微生物群特征与SPIROMICS随访期间肺功能轨迹(稳定/改善、下降或快速下降组)相关。
  • 稳定/改善组(FEV1回归斜率≥第66百分位)基线细菌多样性较高,富集Prevotella、Leptotrichia和Neisseria;快速下降组(FEV1斜率≤第33百分位)基线多样性显著较低,富集Streptococcus。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: The airway microbiome has the potential to shape chronic obstructive pulmonary disease (COPD) pathogenesis, but its relationship to outcomes in milder disease is unestablished. Objectives: To identify sputum microbiome characteristics associated with markers of COPD in participants of the Subpopulations and Intermediate Outcome Measures of COPD Study (SPIROMICS). Methods: Sputum DNA from 877 participants was analyzed using 16S ribosomal RNA gene sequencing. Relationships between baseline airway microbiota composition and clinical, radiographic, and mucoinflammatory markers, including longitudinal lung function trajectory, were examined. Measurements and Main Results: Participant data represented predominantly milder disease (Global Initiative for Chronic Obstructive Lung Disease stage 0-2 obstruction in 732 of 877 participants). Phylogenetic diversity (i.e., range of different species within a sample) correlated positively with baseline lung function, decreased with higher Global Initiative for Chronic Obstructive Lung Disease stage, and correlated negatively with symptom burden, radiographic markers of airway disease, and total mucin concentrations (P < 0.001). In covariate-adjusted regression models, organisms robustly associated with better lung function included Alloprevotella, Oribacterium, and Veillonella species. Conversely, lower lung function, greater symptoms, and radiographic measures of small airway disease were associated with enrichment in members of Streptococcus, Actinobacillus, Actinomyces, and other genera. Baseline sputum microbiota features were also associated with lung function trajectory during SPIROMICS follow-up (stable/improved, decline, or rapid decline groups). The stable/improved group (slope of FEV1 regression ⩾66th percentile) had greater bacterial diversity at baseline associated with enrichment in Prevotella, Leptotrichia, and Neisseria species. In contrast, the rapid decline group (FEV1 slope ⩽33rd percentile) had significantly lower baseline diversity associated with enrichment in Streptococcus species. Conclusions: In SPIROMICS, baseline airway microbiota features demonstrate divergent associations with better or worse COPD-related outcomes.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Opron K, Begley LA, Erb-Downward JR, et al. Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2024. PMID: 38261629. doi:10.1164/rccm.202303-0489OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。